NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES

NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES

Show other versions (1)

<p>New markers for cardiovascular disease (CVD) risk are the subject of an intensive discussion in the scientific literature. The biomarkers (new<br />lipid parameters, inflammatory markers) and signs of subclinical atherosclerosis are candidates to be included in models to assess the cu...

Full description

Bibliographic Details
Main Authors:	D. A. Anichkov, N. A. Shostak
Format:	Article
Language:	Russian
Published:	ABV-press 2014-11-01
Series:	Klinicist
Subjects:	cardiovascular diseases prevention risk rating scales biomarkers clinical guidelines
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/140

Similar Items

NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
by: D. A. Anichkov, et al.
Published: (2014-11-01)

From risk charts to guidelines: tools for evaluation and management of cardiovascular risk
by: Cristina Castello, et al.
Published: (2016-02-01)

Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice
by: Massimo F. Piepoli, et al.
Published: (2018-01-01)

New version of the European guidelines on cardiovascular disease prevention in clinical practice
by: Bekbolat Zholdin, et al.
Published: (2017-06-01)

Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
by: Alyssa M. B. White, et al.
Published: (2020-11-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Systematic review of international clinical guidelines for the promotion of physical activity for the primary prevention of cardiovascular diseases
by: N. Aerts, et al.
Published: (2021-05-01)

DIAGNOSIS FOR RISK FOR FALLS AND THEIR PREVENTION: DRAFT CLINICAL GUIDELINES BY THE ASSOCIATION OF RHEUMATOLOGISTS OF RUSSIA AND THE RUSSIAN OSTEOPOROSIS ASSOCIATION
by: Yu. A. Safonova, et al.
Published: (2020-04-01)

Overview of guidelines for the management of dyslipidemia: EU perspectives
by: Giner-Galvañ V, et al.
Published: (2016-09-01)

Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses
by: Naveen Garg, et al.
Published: (2017-07-01)

Nutritional Recommendations for Cardiovascular Disease Prevention
by: Yaakov Henkin, et al.
Published: (2013-09-01)

MENOPAUSE AND CARDIOVASCULAR RISK
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01)

A practice facilitation-guided intervention in primary care settings to reduce cardiovascular disease risk: a cost analysis
by: Heather T. Gold, et al.
Published: (2021-02-01)

The discussion of risk in German surgical clinical practice guidelines: a qualitative review
by: McLennan Stuart, et al.
Published: (2021-08-01)

Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery
by: M. D. Nigmatkulova, et al.
Published: (2020-12-01)

A new scale for the evaluation of clinical practice guidelines applicability: development and appraisal
by: Hui Li, et al.
Published: (2018-04-01)

Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
by: Lukasz Zandecki, et al.
Published: (2020-06-01)

New clinical and organizational approaches to preventing cardiovascular diseases in the primary health care system
by: S A Boĭtsov, et al.
Published: (2013-08-01)

New АСС/AHA and ESC/ESH arterial hypertension guidelines
by: E. V. Reznik, et al.
Published: (2018-10-01)

Cardiovascular risk assessment in rheumatoid arthritis – controversies and the new approach
by: Krzysztof Bonek, et al.
Published: (2016-07-01)

Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?
by: Németh B, et al.
Published: (2019-07-01)

Biomarkers in predicting cardiovascular risk: new prospects of troponin I
by: A. V. Kontsevaya, et al.
Published: (2020-07-01)

The Impact of the 2019 European Guideline for Cardiovascular Risk Management: A Cross-Sectional Study in General Practice
by: Rahel Meier, et al.
Published: (2020-07-01)

Bring hypertension guidelines into play : guideline-based decision support system for drug treatment of hypertension and epidemiological aspects of hypertension guidelines
by: Persson, Mats
Published: (2003)

METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE
by: M. S. Berezhnova
Published: (2016-01-01)

Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed
by: Zümrüt Alpinar-Sencan, et al.
Published: (2020-05-01)

CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE
by: A. V. Kontsevaya, et al.
Published: (2016-01-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

EVALUATION OF CARDIOVASCULAR RISK FACTORS PREVALENCE AND EFFICACY OF THEIR CORRECTION IN PHYSICIANS. ESTIMATION OF PHYSICIANS’ EXPERTISE IN UP-TO-DATE CLINICAL GUIDELINES. RESULTS OF THE “PHYSICIAN’S HEALTH AND EDUCATION” STUDY
by: L. Y. Drozdova, et al.
Published: (2016-01-01)

CARDIOVASCULAR PREVENTION 2017. NATIONAL GUIDELINES
by: article Editorial
Published: (2018-07-01)

Algorithms for cardiovascular disease prevention
by: Sandeep Seth, et al.
Published: (2016-01-01)

Clinical Guidelines (pedoman pelayanan klinis/medis)
by: Alan R Tumbelaka
Published: (2016-12-01)

Cardiovascular risk and obesity
by: C. Cercato, et al.
Published: (2019-08-01)

ACC/AHA Guidelines for Cardiovascular Disease Prevention and Cholesterol Management: Implications of New Therapeutic Agents
by: Nathan D. Wong, PhD, FACC, FAHA, FNLA
Published: (2016-09-01)

ACCORDING TO THE MATERIALS OF THE 2015/2016 NEW EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) GUIDELINES FOR REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY ARTHRITIS: GENERAL CHARACTERIZATION AND DISCUSSION PROBLEMS
by: T. V. Popkova, et al.
Published: (2018-07-01)

Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study
by: Ranya A. Ghamri, et al.
Published: (2019-11-01)

New European Society of Cardiology Guidelines on diabetes; prediabetes, and cardiovascular diseases - a truly strong base for the major paradigm shift in clinical practice?
by: Zlatko Fras
Published: (2019-11-01)

Visual and measured clinical phenotypes: Potential targets for cardiovascular prevention
by: Chunsong Hu, et al.
Published: (2019-01-01)

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
by: Devinder S. Dhindsa, et al.
Published: (2020-05-01)

Cannot write session to /tmp/vufind_sessions/sess_84il5tmqkbt8o6630s6vthrq4h